The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Abstract
Circumstantial evidence has suggested that activated microglia may be associated with the pathogenesis of depression. Pro-inflammatory cytokines may also be involved. Therefore, we examined the effects of various types of antidepressants, as well as the mood-stabilizer lithium chloride, on interferon-gamma (IFN-gamma)-induced microglial production of the pro-inflammatory mediators interleukin-6 (IL-6) and nitric oxide (NO). Treatment of the murine microglial 6-3 cells with 100 U/ml of IFN-gamma resulted in an eightfold increase in IL-6 and a tenfold increase in NO into the culture medium. Pretreatment with the selective serotonin reuptake inhibitor fluvoxamine, the relatively selective noradrenaline reuptake inhibitor reboxetine, or the non-selective monoaminergic reuptake inhibitor imipramine, significantly inhibited IL-6 and NO production in a dose-dependent manner. These inhibitions were reversed significantly by SQ 22536, a cyclic adenosine monophosphate (cAMP) inhibitor, and, except for reboxetine, by the protein kinase A (PKA) inhibitor Rp-adenosine3',5'-cyclic monophosphorothioate triethylammonium salt (Rp-3',5'-cAMPS). Lithium chloride, which is believed to act by inhibiting the calcium-dependent release of noradrenaline, had a different spectrum of action on microglial 6-3 cells. It enhanced IFN-gamma-stimulated IL-6 production and inhibited NO production. The inhibitory effect of lithium chloride was not reversed by either SQ 22536 or Rp-3',5'-cAMPS. These results suggest that antidepressants have inhibitory effects on IFN-gamma-activated microglia and these effects are, at least partially, mediated by the cAMP-dependent PKA pathway. On the other hand, the mood stabilizer and anti-manic agent lithium chloride has mixed effects on IFN-gamma-induced microglial activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pretreatment with imipramine, fluvoxamine, or reboxetine inhibited NO production in a dose-dependent manner in an activated microglia cell culture protocol [11].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [11]
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Self-citationThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 630
Vallières, L., Campbell, I. L., Gage, F. H., & Sawchenko, P. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00486.2002 · Cited by 608
Cited by
Sorted by citations
Items 101–197 of 197
Choi, H.-S., Park, J. H., Ahn, J. H., Hong, S., Cho, J. H., Won, M., & Lee, C. H. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.10.001 · Cited by 35
Macrophages and depression – A misalliance or well-arranged marriage?
Roman, A., Kreiner, G., & Nalepa, I. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71528-7 · Cited by 34
Sun, X., Zhang, T., Zhao, Y. D., Cai, E., Zhu, H., & Liu, S. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153348 · Cited by 34
Rafiee, L., Hajhashemi, V., & Javanmard, S. H. (2016) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2016.7598 · Cited by 33
Park, B.-K., Kim, Y. H., Kim, Y. R., Choi, J. J., Yang, C., Jang, I., & Lee, M. Y. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7585896 · Cited by 33
Tan, X., Zhang, L., Wang, D., Guan, S., Lu, P., Xu, X., & Xu, H. (2021) · Aging · doi:10.18632/aging.203746 · Cited by 35
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
Cantó, A. A., López-Abellán, M. D., Guardiola, V. C., Hurtado, A. M., PENELLA, M. M., Luengo‐Gil, G., & Conesa‐Zamora, P. (2022) · Cancers · doi:10.3390/cancers14133248 · Cited by 32
Song, J. H., Marszalec, W., Kai, L., Yeh, J. Z., & Narahashi, T. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.041 · Cited by 30
Rafiee, L., Hajhashemi, V., & Javanmard, S. H. (2019) · Central European Journal of Immunology · doi:10.5114/ceji.2019.84011 · Cited by 29
Electromagnetic pulse activated brain microglia via the p38 MAPK pathway
Yang, L., Zhou, Y., Tian, W., Li, H.-J., Kang-Chu-Li, Miao, X., An, G., Wang, X., Guo, G., & Ding, G. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.008 · Cited by 29
Evaluation of lithium serum level in multiple sclerosis patients: A neuroprotective element
Karimi, A., Bahrampour, K., Momeni‐Moghaddam, M. A., Asadikaram, G., Ebrahimi, G., Torkzadeh‐Mahani, M., Tarzi, M. E., & Nematollahi, M. H. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.08.019 · Cited by 30
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Hatamnejad, M. R., Baradaran Ghavami, S., Shirvani, M., Asghari Ahmadabad, M., Shahrokh, S., Farmani, M., Sherkat, G., Asadzadeh Aghdaei, H., & Zali, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980189 · Cited by 28
Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 28
Lauterbach, E. C. (2016) · Europe PMC (PubMed Central) · Cited by 27
Obregon, D. F., Parker-Athill, E. C., Tan, J., & Murphy, T. K. (2012) · Neuropsychiatry · doi:10.2217/npy.12.41 · Cited by 25
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 26
Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
Lauterbach, E. C., Shillcutt, S. D., Victoroff, J., Coburn, K. L., & Mendez, M. F. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.2.130 · Cited by 22
Nutritional Interventions in Clinical Depression
Rechenberg, K. (2015) · Clinical Psychological Science · doi:10.1177/2167702614566815 · Cited by 22
Lithium and Erectile Dysfunction: An Overview
Sheibani, M., Ghasemi, M., & Dehpour, A. R. (2022) · Cells · doi:10.3390/cells11010171 · Cited by 24
Sternberg, Z. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.012 · Cited by 22
Modulation of microglial function by the antidepressant drug venlafaxine 28 November 2014
Dubovický, M., Császár, E., Melicherčíková, K., Kuniaková, M., & Račková, L. (2014) · Interdisciplinary Toxicology · doi:10.2478/intox-2014-0029 · Cited by 22
Ślusarczyk, J., Trojan, E., Głombik, K., Piotrowska, A., Budziszewska, B., Kubera, M., Popiołek-Barczyk, K., Lasoń, W., Mika, J., & Basta‐Kaim, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13452 · Cited by 23
RetractedSelective Serotonin Reuptake Inhibitors
Belagaje, S. R., Brahmbhatt, D., & Abramoff, B. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-49963-0_23 · Cited by 22
Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis
Dhami, K., Churchward, M. A., Baker, G. B., & Todd, K. G. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14661 · Cited by 22
The role of T-lymphocytes in central nervous system diseases
Shen, J., Bian, N., Zhao, L., & Wei, J. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110904 · Cited by 20
El‐Sheikh, A. A. K., & Kamel, M. Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.106 · Cited by 19
Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
Ștefan, M.-G., Kiss, B., Gutleb, A. C., & Loghin, F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02721-6 · Cited by 19
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
The Association Between Psychotropic Drug Use and Fertility Problems Among Male Subjects
Solomon, R., Shvartsur, R., & Azab, A. N. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000353 · Cited by 18
Gao, W., Gao, Y., Xu, Y., Liang, J., Sun, Y., Zhang, Y., Shan, F., Ge, J., & Xia, Q. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05910-0 · Cited by 16
Vasilopoulou, F., Bagán, A., Rodríguez‐Arévalo, S., Escolano, C., Griñán‐Ferré, C., & Pallàs, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050475 · Cited by 17
Restorative therapies to enhance sensorimotor recovery following cerebral ischemia
Ortega, F. J., & Jolkkonen, J. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1922 · Cited by 16
Higaki, H., Choudhury, M. E., Kawamoto, C., Miyamoto, K., Islam, A., Ishii, Y., Miyanishi, K., Takeda, H., Seo, N., Sugimoto, K., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.013 · Cited by 17
Lee, E., Oh, M. S., Kim, J. S., Chang, D., Park, J., Cha, J., Heo, J. H., Sohn, S., Kim, D., Kim, H. Y., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316882 · Cited by 17
Role of Sirtuins in Linking Metabolic Syndrome with Depression
Song, J., & Kim, J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00086 · Cited by 16
Li, Q., Yang, T., Guo, A., & Fan, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8378 · Cited by 16
Xu, J., Zou, J., Zhang, D., Zhang, K., Qi, Y., Yan, C., Lee, E., Jia, Q., Ma, C., & Jiang, H. B. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101541 · Cited by 15
Fei, L., Santarelli, G., D’Anna, G., Moretti, S., MIROSSI, G., Patti, A., Sanfilippo, G., Almerigogna, F., Berni, A., Caldini, E., et al. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04436-0 · Cited by 16
The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools
Marinho, L. S. R., Chiarantin, G. M. D., Ikebara, J. M., Cardoso, D. S., de Lima-Vasconcellos, T. H., Higa, G. S. V., Ferraz, M. S. A., Pasquale, R. D., Takada, S. H., Papes, F., et al. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.007 · Cited by 35
Cai, Y., Zhu, Z. H., Li, R. H., Yin, X. Y., Chen, R. F., Man, L. J., Hou, W. L., Zhu, H. L., Wang, J., Zhang, H., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04616-z · Cited by 15
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis
Sanabra, C., Johansson, E. M., & Mengod, G. (2012) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.12.005 · Cited by 15
High Serum Levels of INOS and MIP-1α Are Associated with Post-Stroke Depression
Wang, X., Fang, C., Liu, X., Wei, W., Zhang, M., Chen, S., & Shi, F. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s320072 · Cited by 14
Slyepchenko, A., Brunoni, A. R., McIntyre, R. S., Quevedo, J., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144601 · Cited by 14
Rafiee, L., Esfahani, H. N., & Javanmard, S. H. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_141_18 · Cited by 14
Sadeghipour, H., Dehghani, M., Ghasemi, M., Riazi, K., Asadi, S., Ebrahimi, F., Honar, H., Hajrasouliha, A. R., Tavakoli, S., Sianati, S., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.054 · Cited by 14
Suppressive Effect of Imipramine on Vincristine-Induced Mechanical Allodynia in Mice
Saika, F., Kiguchi, N., Kobayashi, Y., Fukazawa, Y., Maeda, T., Ozaki, M., & Kishioka, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1231 · Cited by 14
ADptive plasticity and recovery in preclinical models of stroke
Dalise, S., Ambrosio, F., & Modo, M. (2015) · ARCHIVES ITALIENNES DE BIOLOGIE · doi:10.12871/00039829201442 · Cited by 19
Nakatani, Y., Yaguchi, M., Ogino, K., Noguchi, R., Yamamoto, N., & Amano, T. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06194-6 · Cited by 12
Zhu, Z. H., Song, X. Y., Man, L. J., Chen, P., Tang, Z., Li, R. H., Ji, C., Dai, N. B., Liu, F., Wang, J., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.858675 · Cited by 12
GABAB receptor intracellular signaling: novel pathways for depressive disorder treatment?
Korczak, M., Kurowski, P. N., Leśniak, A., Grönbladh, A., Filipowska, A., & Bujalska‐Zadrożny, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173531 · Cited by 13
Oxidative Stress in Depression
Gałecki, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_190 · Cited by 11
Loftis, J. M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.017 · Cited by 11
Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage
Kim, D. W., Kim, D., Kim, M. J., Kwon, S.-W., Ahn, E.-H., Jeong, H.-J., Sohn, E. J., Dutta, S., Lim, S. S., Cho, S., et al. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.10.647 · Cited by 11
Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
Faour-Nmarne, C., & Azab, A. N. (2015) · Innate Immunity · doi:10.1177/1753425915613425 · Cited by 11
Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation
Fujimori, K., Takaki, J., Shigemoto‐Mogami, Y., Sekino, Y., Suzuki, T., & Sato, K. (2014) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.09.002 · Cited by 10
Ghasemi, M., Karimollah, A. R., & Dehpour, A. R. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.08.002 · Cited by 10
Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle
Karimollah, A. R., Ghasemi, M., Ghahremani, M. H., & Dehpour, A. R. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.08.007 · Cited by 9
Nicolai, L., Nettesheim, P., de Witte, L. D., & Snijders, G. J. L. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100465 · Cited by 9
Effect of topical neuromodulatory medications on oral and skin keratinocytes
Al‐Musawi, M., Durham, J., Whitworth, J. M., Stone, S. J., Nixdorf, D. R., & Valentine, R. A. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12437 · Cited by 8
Imipramine and Venlafaxine Differentially Affect Primary Glial Cultures of Prenatally Stressed Rats
Obuchowicz, E., Bielecka, A., Zielinski, M. W., Machnik, G., Gołyszny, M. J., & Ludyga, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01687 · Cited by 8
Matt, S. M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100353 · Cited by 8
Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19
Anar, M. A., Foroughi, E., Sohrabi, E., Peiravi, S., Tavakoli, Y., Khouzani, M. K., Behshood, P., Shamshiri, M., Faridzadeh, A., Keylani, K., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1036093 · Cited by 11
Matsuo, K., Watanabe, M., Inamine, S., Matsushima, T., Kyuragi, S., Maeda, Y., Katsuki, R., Ohgidani, M., Yamasaki, R., Isobe, N., et al. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2452842 · Cited by 7
Self-citationPotential Neuroimmunological Targets in the Treatment of Anxiety Disorders
Hou, R. H., Tang, Z., & Baldwin, D. S. (2013) · Modern trends in psychiatry · doi:10.1159/000351965 · Cited by 7
Antidepressant pharmacotherapy: focus on sex differences in neuroimmunopharmacological crossroads
Pitychoutis, P. M., Tsitsilonis, O., & Papadopoulou‐Daifoti, Z. (2010) · Future Neurology · doi:10.2217/fnl.10.28 · Cited by 7
Interleukin-8 is a potential inflammation biomarker in major depressive disorder
Versel, J. L., Cantos, A., Castillo, M. F. R., Fatourou, E., Sinacore, J. M., & Halaris, A. E. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100828 · Cited by 6
Impact of imipramine on proteome of rat primary glial cells
Kędracka–Krok, S., Świderska, B., Bielecka, A., Pruś, G., Skupień-Rabian, B., Jankowska, U., & Obuchowicz, E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.008 · Cited by 6
Neuroprotective effects of lithium in neuropsychiatric disorders
Agam, G., & Levine, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00006-9 · Cited by 6
Beckman, D., & Linden, R. (2016) · Prion · doi:10.1080/19336896.2016.1152437 · Cited by 5
Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota
Shi, M., Li, Z., Tang, Z., Zhou, H., Huang, X., Wei, Y., Li, X., Li, X., Shi, H., & Qin, D. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111022 · Cited by 4
Smaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_176 · Cited by 5
Role of Neurotoxicity in Depression
Smaga, I., Krzyżanowska, W., Pomierny, B., Budziszewska, B., Pilc, A., & Nowak, G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_176 · Cited by 3
Do Antidepressants Exert Effects on the Immune System?
Halaris, A. E. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_16 · Cited by 3
Selective Serotonin Reuptake Inhibitors
Saad, A. K., Nguyen, P., & Belagaje, S. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-17750-2_20 · Cited by 3
Inflammation in the Pathogenesis of Depression
Connor, T. J., & Harkin, A. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch11 · Cited by 2
Chiang, P.-Y., Liao, C.-Y., Wu, C.-Y., Kao, W., Lin, Y.-T., Wei, P.-H., Tung, T.-H., & Huang, S.-Y. (2026) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2026.102747 · Cited by 1
Yirmiya, D., Rimmerman, N., & Reshef, R. (2015) · Cited by 1
Brand, S. J. (2011) · Cited by 1
Brain Inflammation and the Neuronal Fate: from Neurogenesis to Neurodegeneration
Ajmone‐Cat, M. A., Cacci, E., & Minghetti, L. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0013 · Cited by 1
Microglial properties in health and disease
Krabbe, G. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15999
Abdel‐Salam, O. M. E., Morsy, S., & Sleem, A. A. (2011)
Oxidative Stress in Depression 103
Gaøecki, P. (2014)
Antidepressants Modulate Microglia Beyond the Neurotransmitters Doctrine of Mood Disorders
Ohgidani, M., Kato, T. A., Mizoguchi, Y., Horikawa, H., Monji, A., & Kanba, S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_36
Self-citationWong, A. P. (2010) · TSpace (University of Toronto)
Feinstein, D. L., & Heneka, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805088-0.00016-5
Antidépresseurs : aspects pharmacologiques
Gauthier, C., Souaiby, L., Poirier, M., Olié, J., Krebs, M., & Gaillard, R. (2016) · Time to knit · doi:10.1016/s0246-1072(16)75754-3
The effect of topical neuromodulatory medications on orofacial tissue in vitro
Al‐Musawi, M. (2016)
Modulating Microglial Activation As a Possible Therapeutic Target for Depression
Sato‐Kasai, M., Kato, T. A., Ohgidani, M., Horikawa, H., Mizoguchi, Y., Monji, A., & Kanba, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_18
Self-citationК., І., N.Zh., C., Yo., N., T., N., H., S., T., H., F, Y., M., A., M., S. D., А, Б. Г., et al. (2019) · Наука и здравоохранение · doi:10.34689/sh.2019.21.4.011
Self-citationSmaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_176-1
第110回日本精神神経学会学術総会 教育講演 宗教(カトリシズム,プロテスタンティズム,仏教)が医療に果たした役割 : わが国の緩和医療の今後を考えながら
加藤, 敏. (2014) · 精神神経学雑誌
Immunological and behavioral consequences of high-fat diet feeding in mice
Lavin, D. N. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Cai, Y., Zhu, Z. H., Li, R. H., Yin, X. Y., Chen, R. F., Man, L. J., Hou, W. L., Zhu, H. L., Wang, J., Zhang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570938
The activation of glial cells is involved in the pain and pruritus in allergic contact dermatitis
Dai, W., Zhang, Z., Xu, T., Cai, K., Luo, A., Luo, Z., Wang, R., Lai, Z., Wang, J., & Nie, H. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.01.007
Microgliopathy in poststroke depression: exploring mechanisms and therapeutic strategies
Yang, C., Wu, S., Cao, H., Yin, Y., Zhang, Y., Zhang, L., Chen, R., & Tao, X. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.08.046
Metadata
- Authors
- Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S.
- Affiliations
- Kyushu University (JP)
- University of British Columbia (CA)
- Research Institute of Environmental Medicine, Nagoya University (JP)
- Corresponding author
- Hashioka, Sadayuki
- Monji, Akira
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 206
- Issue
- 1
- Pages
- 33-42
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1970022478
- Cited by
- 198
- References
- 42
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 7 · 2016: 18 · 2015: 16 · 2014: 18 · 2013: 14 · 2012: 18
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- antidepressants, microglia, interferon-gamma, interleukin-6, nitric oxide, fluvoxamine, reboxetine, imipramine, lithium chloride, cAMP signaling, protein kinase A, microglial activation, depression, inflammatory cytokines, mood stabilizers
- MeSH terms
- Cyclic AMP, Animals, Antidepressive Agents, Antiviral Agents, Brain, Cell Line, Depressive Disorder, Dose-Response Relationship, Drug, Enzyme Inhibitors, Interferon-gamma, Mice, Inbred C57BL, Nitric Oxide, Neurotransmitter Uptake Inhibitors, Interleukin-6, Up-Regulation, Microglia, Cyclic AMP-Dependent Protein Kinases, Lithium Chloride, Antimanic Agents, MAP Kinase Signaling System, Mice, Cyclic AMP-Dependent Protein Kinase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review